EIKO LIFESCIENCES LTD Q2 RESULTS
Tata Elxsi Q1 Results: Net profit falls 3% YoY to Rs 184 crore
Tata Elxsi Q1 Results: Revenue from operations for the reporting period grew by 9% year-on-year, reaching Rs 926 crore compared to Rs 850 crore in the same period last year. Sequentially, net profit for the quarter dropped by 6% from Rs 196 crore in the preceding December quarter. However, revenues increased by 2% quarter-on-quarter. Total expenses for the first quarter rose by 13% year-on-year to Rs 706 crore, compared to Rs 624 crore in the same quarter last year.
Q4 results: Stable costs boost India Inc. profits
Steady costs and firm domestic demand supported corporate performance in the March quarter.
Zydus Lifesciences Q4 Results: Drug makers posts threefold YoY jump in net profit to Rs 1,182 crore
Zydus Lifesciences on Friday reported Rs 1,182 crore net profit in Q4FY24, a threefold year-on-year (YoY) jump led by growth in US, India, Europe and emerging market sales.
Zydus Lifesciences Q3 Results: Firm beats profit estimates; approves shares buyback
Indian generic drugmaker Zydus Lifesciences reported a bigger-than-expected rise in third-quarter profit on Friday, driven by strong sales in its domestic and overseas markets.
Wipro Q3 Results: Consolidated PAT drops 12% YoY to Rs 2,694 crore; Re 1/share interim dividend announced
Wipro Q3 Results: Wipro reported disappointing Q3 results, with a decline in net profit and revenue. The company's consolidated net profit decreased by nearly 12% YoY to Rs 2,694 crore, while the consolidated revenue dropped 4.4% to Rs 22,205 crore. The board recommended an interim dividend of Re 1 per share. For the nine months ended December, Wipro's consolidated revenue rose by only 0.4% to Rs 67,552 crore, while the net profit declined by nearly 1% to Rs 8,211 crore. Wipro expects revenue from its IT Services business to be in the range of $2.62 billion to $2.67 billion for the quarter ending March.
Glenmark Pharma Q2 Results: Co posts loss on exceptional legal costs
The company posted a consolidated net loss, from continuing operations, of 2.01 billion rupees ($24.14 million) for the three months ended Sept. 30, from a profit of 1.54 billion rupees a year ago
- Go To Page 1
Zydus Lifesciences Q2 Results: Firm reports 53% YoY jump in net profit at Rs 801 crore
Revenue from operations rose 9.1% YoY to Rs 4369 crore in Q2FY24 compared to Rs 4006 crore in Q2FY23. On QoQ revenue declined 15%. The earnings before interest, tax, depreciation and ammortisation (EBITDA) increased 40.6% YoY to Rs 1146 crore. On QoQ, EBITDA dropped 23.9%.
Zydus Q2 Results: Profit jumps on strong domestic, US demand
India's generic drug makers, which draw a significant share of revenue from the crucial U.S. market, are recovering from the effects of eroding prices in the largest drug market in the world.
Q2 results this week: Adani Ports, Tata Power, LIC, RVNL, M&M and others
Power Grid, Shree Cements, Trent, Zydus Lifesciences, Info Edge (India), Indian Railway Catering & Tourism Corporation, Cummins India, Alkem Laboratories, UNO Minda, Prestige Estates Projects, among others will release their Q2 earnings on November 7
Infosys Q2 Results: PAT rises 3% YoY to Rs 6,212 crore; firm trims FY24 revenue guidance
Infosys has reported a 3% YoY growth in consolidated net profit for the quarter ended September. The company's consolidated revenue also grew nearly 7% YoY. Infosys has tweaked its guidance for FY24, expecting revenue growth of 1.0-2.5% in constant currency terms. The company retained its operating margin target of 20-22%. Infosys announced large TCV deals worth $7.7 billion for the quarter and saw a decline in attrition rate.
Persistent Systems Q1 Results: Profit rises 8% YoY to Rs 229 crore; revenue jumps 23%
Revenue from operations during the first quarter rose 23% year-on-year to Rs 2,321 crore. It was Rs 1,878 crore in the same quarter of last year.
Infosys Q1 Results: PAT rises 11% YoY to Rs 5,945 cr; firm sharply trims FY24 revenue growth guidance
Taking note of the uncertain global environment, the software major sharply cut its FY24 revenue growth estimate. Infosys now sees revenue growing just 1-3.5% in constant currency terms, against 4-7% earlier.
HCL Tech Q1 Results: Profit rises 8% YoY to Rs 3,534 crore, misses estimates
HCLTech’s attrition for the quarter stood at 16.3% compared to 19.5% reported last quarter. The 12-month trailing attrition rate is at 16.3%, compared to 19.5% a quarter ago. Its headcount in the first quarter stood at 223,438 with a drop of 2,506 over the previous quarter, said Ramachandran Sundararajan, chief people officer. The company, however, added 1,597 freshers during the quarter.
TCS Q1 Results: Profit rises 17% YoY to Rs 11,074 crore, beats estimates; revenue up 13%
While the net profit was above the ET Now poll of Rs 10,890 crore, the revenue was tad lower than the estimated Rs 59,500 crore. Sequentially, the topline rose a mere 0.4%, making this the slowest growth in 12 quarters for the country’s largest software exporter. The profit declined nearly 3% from the March quarter.
Q1 earnings: 26 companies that may report over 100% jump in profit
Domestic brokerage Motilal expects Nifty earnings to grow 25% YoY in Q1. Oil and gas sector may report a 3x surge in profit YoY underpinned by the improvement in marketing margins of OMCs. Auto sector’s earnings may surge 11x YoY during the quarter on a low base.
Q1 results this week: TCS, HCL Tech, Wipro, Avenue Supermarts, Angel One and others
The June quarter earnings are seen to be weaker than expected amid uncertain and global environment and a slowdown in discretionary spending by clients
For risk takers: 5 midcap stocks that have moved from negative to neutral score can rise up to 22%
As Nifty comes closer to form a new high, more number of mid-caps stocks are joining the party. Some stocks which had been trading earlier in negative territory have seen an improvement in their score which means a big shift in stance of analysts. ET screener powered by Refinitiv’s Stock Report Plus applies different algorithms & filters to all BSE and NSE stocks, and lists stocks which fulfill the various criteria as specified into the algorithms & filters to find those which might help navigate the stock market.
Zydus Lifesciences Q4 Results: Consolidated net profit dips 25% to Rs 297 crore
Zydus Lifesciences Ltd reported a 25.36% decline in consolidated net profit at Rs 296.6 crore in the fourth quarter ended March 31, 2023 impacted by impairment of goodwill of a wholly-owned subsidiary. The company, which had posted a consolidated net profit of Rs 397.4 crore in the same quarter of the previous fiscal, said its board has recommended a final dividend of Rs 6 per equity share of Re 1 each, subject to approval of shareholders at the
Q3 results impact: Tata Motors, Zomato among over 35 stock upgrades and downgrades
A team of analysts from global brokerage firm Jefferies has raised the FY23 earnings estimates for 47% of 147 companies under its coverage network. Downgrades were made to 46% of companies, resulting in higher upgrades than downgrades for the first time in five quarters.
Q3 results this week: L&T, Bajaj Finserv, Sun Pharma, Tech Mahindra, Ashok Leyland and others
Results that will be out on January 30 include Larsen & Toubro, Bajaj Finserv, Tech Mahindra, Bharat Petroleum Corporation, Bajaj Holdings & Investment, GAIL, SRF, Punjab National Bank, REC, Laurus Labs, IIFL Finance, Trident, Exide Industries, Nippon Life India Asset Management, Mazagon Dock Shipbuilders, Welspun as well as Inox Leisure.
Q2 results this week: Tata Motors, Adani Green, Coal India, Paytm, LIC and more
Tata Motors, Pidilite Industries, Procter & Gamble Hygiene & Healthcare, Star Health and Allied Insurance Company, Godrej Properties, Deepak Nitrite, 3M India, General Insurance Corporation of India, Piramal Enterprises, The Ramco Cements, Finolex Cables, Quess Corp, Balrampur Chini Mills, Gujarat Alkalies & Chemicals, Edelweiss Financial Services, New Delhi Television, Max Ventures and Industries.
Corporate Radar: Sikko Industries to trade ex-bonus, Maruti, Vedanta, Tata Power Q2 results and more
Shares of IIFL Wealth (Rs 17 per share), KPI Green (Re 0.25 per share) and Focus Business (Re 0.38 per share) shall trade ex-dividend today.
Corporate Radar: Coal India, IOC to turn ex-dividend; Apollo Hospitals Q1 results; AGMs, and more
Apollo Hospitals Enterprise, Page Industries, Trent, Aurobindo Pharma, Bharat Forge, The Phoenix Mills and Sunteck Realty are among companies that will announce their quarterly earnings today.
Zydus Lifesciences Q1 Results: Net Profit drops 12% YOY to Rs 518 crore
The earnings before interest, tax, depreciation and ammortisation (EBITDA) was Rs 833 crore, a decline of 14.3% YoY. On QoQ, EBITDA rose 16.1%.The EBITDA margins for the quarter dropped 190 basis points to 20.5% in Q1FY23 compared to 24.3% in Q1FY22. On QoQIndia sales saw a drop of 6.5% YoY to Rs 1817 crore in Q1FY23. The formulation business dropped .
Corporate Radar: NTPC to turn ex-dividend; Coal India Q1 results; AGMs, and more
Abbott India, United Breweries, Zydus Lifesciences, Cummins India, The Ramco Cements, Cholamandalam Financial Holdings, Sobha, Ingersoll-Rand (India), S H Kelkar & Company, Pricol, Ramco Industries and Ramco Systems will have their annual general meetings (AGM) today.
Corporate Radar: L&T to turn ex-dividend; Hindustan Zinc, PVR Q1 results & more
Shares of Hindustan Foods, Ontic Finserve, Rajnish Wellness and Shanti Educational Initiatives will go ex-split today. Hindustan Foods and Rajnish Wellness had announced the splitting of shares into face value of Re 2 from the face value of Rs 10 while Ontic Finserve and Shanti Educational Initiatives had announced the splitting of shares into face value of Re 1 from the face value of Rs 10.
Corporate Radar: HUL, HDFC Life Q1 results; Federal Bank to turn ex-dividend; AGMs & more
Hindustan Unilever, HDFC Life Insurance, Ambuja Cements, ICICI Lombard General Insurance, AU Small Finance Bank, Polycab India, Hatsun Agro Product, L&T Finance Holdings and DCM Shriram are among companies that will announce their quarterly earnings today.
Corporate Radar: LIC Q4 results, JSW Steel's dividend, Tilaknagar's referential issue & more
LIC, Sun Pharma, IRCTC, Jindal Steel & Power, Delhivery, Jubilant FoodWorks and Aurobindo Pharma are among the companies which will announce their quarterly earnings today.
Glenmark Q4 Results: Net dips 26% to Rs 173 cr
Consolidated revenues of the drug firm, however, rose to Rs 3,019 crore in the quarter under review as compared to Rs 2,860 crore in the year-ago period, recording an increase of 6 per cent year-on-year.For the year ended March 31, 2022, the Mumbai-based drug firm reported a PAT of Rs 994 crore, as against Rs 970 crore in FY21.
Load More
